Biosimilars in rheumatology: a view from Latin America
Author:
Publisher
Springer Science and Business Media LLC
Subject
General Medicine,Rheumatology
Link
http://link.springer.com/content/pdf/10.1007/s10067-012-2068-3.pdf
Reference9 articles.
1. Pisetsky DS, Ward MM (2012) Advances in the treatment of inflammatory arthritis. Best Pract Res Clin Rheumatol 26:251–261
2. Mellstedt H, Niederwieser D, Ludwig H (2008) The challenge of biosimilars. Ann Oncol 19(3):411–419, Epub 2007 Sep 14. Review
3. Knezevic I, Griffiths E (2011) Biosimilars—global issues, national solutions. Biologicals 39(5):252–255, Epub 2011 Sep 15. Review
4. Colbert RA, Cronstein BN (2011) Biosimilars: the debate continues. Arthritis Rheum 63:2848–2850
5. Kay J (2011) Biosimilars: a regulatory perspective from America. Arthritis Res Ther 13(3):112
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Knowledge, Perceptions, and Utilization of Generics and Biosimilars in Latin America and the Caribbean: A Scoping Review;Journal of Law, Medicine & Ethics;2023
2. Technological development and patent analysis: the case of biopharmacy in the world and in Latin America;Tapuya: Latin American Science, Technology and Society;2022-10-14
3. Drug prices in Latin American countries: the case of rheumatoid arthritis Biosimilars;Advances in Rheumatology;2021-02-25
4. PANLAR consensus statement on biosimilars;Clinical Rheumatology;2019-03-27
5. Biosimilars: An Approach to some Current Worldwide Regulation Frameworks;Current Clinical Pharmacology;2019-03-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3